tiprankstipranks
Titan Pharmaceuticals (TTNP)
NASDAQ:TTNP

Titan Pharmaceuticals (TTNP) Ownership - Who Owns Titan Pharmaceuticals?

783 Followers

Recent Insider Trading Activity

Date
Name
Activity
Value
Jun 23, 2023
David E. Lazar
Ceo,director
Sold$4610001

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
556,317Insider60.85%4,052,769
490,262Insider53.63%3,571,559
213,000Insider23.30%1,551,705
182,500Insider19.96%1,329,513
112,500Insider12.31%819,563
102,275Insider11.19%745,073
82,051Institution8.97%597,742
59,822Institution6.54%435,803
52,690Insider5.76%383,847
36,144Insider3.95%263,309

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value
82,051Institution8.97%597,742
59,822Institution6.54%435,803

Top ETF Holders

Holder
# of Shares
Type
% Holding
Value
4,103Institution0.45%29,419

FAQ

Who Owns Titan Pharmaceuticals (TTNP)?
Currently, no data Available
What percentage of Titan Pharmaceuticals (TTNP) stock is held by institutional investors?
Currently, no data Available
What percentage of Titan Pharmaceuticals (TTNP) stock is held by retail investors?
Currently, no data Available
Who owns the most shares of Titan Pharmaceuticals (TTNP)?
Marc Rubin owns the most shares of Titan Pharmaceuticals (TTNP).
    What is the significance of the ownership structure for a publicly traded company?
    The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
      What's Included in PREMIUM?
      Make informed decisions based on Top Analysts' activity
      Know what industry insiders are buying
      Get actionable alerts from top Wall Street Analysts
      Find out before anyone else which stock is going to shoot up
      Get powerful stock screeners & detailed portfolio analysis